Scleromyxoedema treated with autologous stem cell transplantation [18]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 1, 2007, Pages 129-130

  Iranzo, P ^a   Lopez lerma I ^a   Blade J ^b   Rovira, M ^b   Herrero, C ^a  

^a Department of Dermatology ^*  (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADULT; ARTHRALGIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARPAL TUNNEL SYNDROME; CASE REPORT; DEATH; DISEASE COURSE; DRUG MEGADOSE; DRUG RESPONSE; ELECTROMYOGRAPHY; HAND SURGERY; HUMAN; HYPERGLYCEMIA; HYPERPIGMENTATION; JOINT STIFFNESS; LETTER; LUNG DISEASE; MALE; PAPULE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCLEROMYXEDEMA; SKIN BIOPSY; SKIN INDURATION; STEM CELL MOBILIZATION;

COMBINED MODALITY THERAPY; HUMANS; MALE; MELPHALAN; MIDDLE AGED; SCLEROMYXEDEMA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 33845623393     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01814.x     Document Type: Letter

References (8)

1. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-281.
2. Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: A scleroderma-like disorder with systemic manifestations. Medicine (Baltimore) 1988; 67: 58-65.
3. Horn KB, Horn MA, Swan J et al. A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema. J Am Acad Dermatol 2004; 51: S120-S123.
4. Kulczycki A, Nelson M, Eisen A, Heffernan M. Scleromyxoedema: Treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 2003; 149: 1276-1281.
5. Cohen AM, Hodar E, David M, Mittelman M, Gal R, Stern R. Beneficial effect of granulocyte colony-stimulating factor in scleromyxedema associated with severe idiopathic neutropenia. Br J Dermatol 1996; 135: 626-629.
6. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1999; 33: 37-43.
7. Blade J, Vesole DH, Gertz MA. Transplantation for multiple myeloma: Who, when, how often? Blood 2003; 102: 3469-3477.
8. Feasel AM, Donato ML, Duvic M. Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol 2001; 137: 1071-1072.